Inhibition of type III secretion in Salmonella enterica serovar typhimurium by small-molecule inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2631-2635

  Hudson, Debra L ^a   Layton, Abigail N ^a   Field, Terry R ^a   Bowen, Alison J ^a   Wolf Watz, Hans ^b   Elofsson, Mikael ^b   Stevens, Mark P ^a   Galyov, Edouard E ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INP 0007; INP 0403; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; CELL INVASION; CHLAMYDIA; CONTROLLED STUDY; ENTERITIS; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; YERSINIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; MOLECULAR STRUCTURE; SALMONELLA TYPHIMURIUM; SEROTYPING;

EID: 34447273555     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01492-06     Document Type: Article

References (24)

1. Ainscough, E. W., A. M. Brodie, W. A. Denny, G. J. Finlay, S. A. Gothe, and J. D. Ranford. 1999. Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure-activity relationships. J. Inorg. Biochem. 77:125-133.
2. Alksne, L. E., and S. J. Projan. 2000. Bacterial virulence as a target for antimicrobial chemotherapy. Curr. Opin. Biotechnol. 11:625-636.
3. Galan, J. E. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53-86.
4. Gauthier, A, M. L. Robertson, M. Lowden, J. A. Ibarra, J. L. Puente, and B. B. Finlay. 2005. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob. Agents Chemother. 49:4101-4109.
5. Hakansson, S., K. Schesser, C. Persson, E. E. Galyov, R. Rosqvist, F. Homble, and H. Wolf-Watz. 1996. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15:5812-5823.
6. Jones, M. A., M. W. Wood, P. B. Mullan, P. R. Watson, T. S. Wallis, and E. E. Galyov. 1998. Secreted effector proteins of Salmonella dublin act in concert to induce enteritis. Infect. Immun. 66:5799-5804.
7. Kaniga, K., D. Trollinger, and J. E. Galan. 1995. Identification of two targets of the type 111 protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins. J. Bacteriol. 177:7078-7085.
8. Kaniga, K., S. Tucker, D. Trollinger, and J. E. Galán. 1995. Homologs of the Shigella Ipab and Ipac invasins are required for Salmonella typhimurium entry into cultured epithelial cells. J. Bacteriol. 177:3965-3971.
9. Kauppi, A. M., R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson. 2003. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10:241-249.
10. Miki, T., N. Okada, Y. Shimada, and H. Danbara. 2004. Characterization of Salmonella pathogenicity island 1 type III secretion-dependent hemolytic activity in Salmonella enterica serovar Typhimurium. Microb. Pathog. 37:65-72.
11. Morgan, E., J. D. Campbell, S. C. Rowe, J. Bispham, M. P. Stevens, A. J. Bowen, P. A. Barrow, D. J. Maskell, and T. S. Wallis. 2004. Identification of host-specific colonization factors of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 54:994-1010.
12. Muschiol, S., L. Bailey, A. Gylfe, C. Sundin, K. Hultenby, S. Bergstrom, M. Elofsson, H. Wolf-Watz, S. Normark, and B. Henriques-Normark. 2006. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103: 14566-14571.
13. Nordfelth, R., A. M. Kauppi, H. A. Norberg, H. Wolf-Watz, and M. Elofsson. 2005. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73:3104-3114.
14. Olsson, J., P. J. Edqvist, J. E. Broms, A. Forsberg, H. Wolf-Watz, and M. S. Francis. 2004. The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains. J. Bacteriol. 186: 4110-4123.
15. Patel, J. C., O. W. Rossanese, and J. E. Galan. 2005. The functional interface between Salmonella and its host cell: opportunities for therapeutic intervention. Trends Pharmacol. Sci. 26:564-570.
16. Sansonetti, P. J., A. Ryter, P. Clerc, A. T. Maurelli, and J. Mounier. 1986. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect. Immun. 51:461-469.
17. Stender, S., A. Freibel, S. Linder, M. Rohde, S. Mirold, and W. D. Hardt. 2000. Identification of SopE2 from Salmonella Typhimurium, a conserved guanine nucleotide exchange factor Cdc42 of the host cell. Mol. Microbiol. 36:1206-1221.
18. Wallis, T. S., and P. A. Barrow. July 2005, posting date. Chapter 8.6.2.1, Salmonella epidemiology and pathogenesis in food-producing animals. In J. Kaper (ed.), EcoSal-Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC. http://www.ecosal.org.
19. Wallis, T. S., and E. E. Galyov. 2000. Molecular basis of Salmonella-induced enteritis. Mol. Microbiol. 36:997-1005.
20. Wallis, T. S., S. M. Paulin, J. S. Plested, P. R. Watson, and P. W. Jones. 1995. The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect. Immun. 63:2755-2761.
21. Warawa, J., B. B. Finlay, and B. Kenny. 1999. Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 67: 5538-5540.
22. Watson, P. R., E. E. Galyov, S. M. Paulin, P. W. Jones, and T. S. Wallis. 1998. Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. Infect. Immun. 66:1432-1438.
23. Wolf, K., H. J. Betts, B. Chellas-Gery, S. Hower, C. N. Linton, and K. A. Fields. 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61:1543-1555.
24. Wood, M. W., R. Rosqvist, P. B. Mullan, M. H. Edwards, and E. E. Galyov. 1996. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol. Microbiol. 22:327-338.